News
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback